​

Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary

Vanda Pharmaceuticals is owned by 76.30% institutional investors, 6.16% insiders, and 17.54% retail investors. Blackrock is the largest institutional shareholder, holding 14.09% of VNDA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.22% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals76.30%6.16%17.54%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.14M14.09%$45.98M
Blackrock funding, inc. /de7.28M12.31%$50.28M
Renaissance3.76M6.36%$25.98M
Vanguard group3.73M6.34%$32.91M
State street3.02M5.10%$20.84M
Aigh capital management2.75M4.65%$19.00M
Tang capital management2.35M3.99%$11.74M
Millennium management1.88M3.18%$13.00M
Acadian asset management1.80M3.04%$12.40M
Dimensional fund advisors lp1.77M3.00%$12.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management1.18M3.19%$8.16M
Aigh capital management2.75M2.59%$19.00M
Empire financial management company1.11M2.12%$9.77M
Tang capital management2.35M0.45%$11.74M
Monaco asset management sam241.29K0.31%$1.67M
Pharvision advisers57.04K0.16%$284.62K
Scientech research24.76K0.14%$171.10K
Diker management21.88K0.13%$151.19K
One68 global capital26.06K0.06%$119.61K
Inscription capital63.88K0.05%$441.40K

Top Buyers

HolderShares% AssetsChange
State street3.02M0.00%1.75M
Aqr capital management1.60M0.01%976.57K
Aigh capital management2.75M2.59%751.57K
Citadel advisors633.35K0.00%633.35K
Marshall wace, llp596.00K0.00%596.00K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.59M
Bank of america corp /de/77.42K--1.13M
Assenagon asset management---730.82K
Acadian asset management1.80M0.02%-614.82K
Blackrock funding, inc. /de7.28M0.00%-497.55K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust387.96K0.00%387.96K$2.68M
Arrowstreet capital, limited partnership241.43K0.00%241.43K$1.67M
Woodline partners lp207.67K0.01%207.67K$1.43M
Virtu financial128.28K0.04%128.28K$886.00K
Norges bank115.00K0.00%115.00K$550.85K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Nelson, van denburg & campbell wealth management group-10.00
Clearstead advisors-23.00
Gps wealth strategies group-25.00
Assetmark-31.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261684.35%45,092,0277.65%761.52%10752.86%38-39.68%
Dec 31, 202538-75.64%6,341,924-85.88%100.19%17-76.06%12-77.36%
Sep 30, 202551-64.34%6,811,734-84.86%110.20%22-67.65%15-67.39%
Jun 30, 2025142-7.79%44,993,3852.43%761.35%673.08%46-16.36%
Mar 31, 20254-97.33%2,360,082-94.49%40.07%3-95.95%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF1.94M3.22%-19.13K
Vanguard US Total Market Shares ETF1.74M2.99%-
Vanguard Total Stock Mkt Idx Inv1.76M2.93%-
iShares Russell 2000 ETF1.31M2.19%11.09K
Vanguard Institutional Extnd Mkt Idx Tr669.25K1.11%4.06K
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K
Fidelity Small Cap Index546.07K0.91%9.22K
BlackRock Advantage Small Cap Core Instl489.96K0.81%-
iShares Russell 2000 Value ETF468.05K0.78%2.52K
DFA US Targeted Value I444.72K0.75%13.19K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 02, 2026Williams Timothy SVP & General CounselSell$350.76K
Mar 02, 2026Moran Kevin Patrick SVP, CFO & TreasurerSell$350.82K
Mar 02, 2026Wijkstrom Joakim SVP, Chief Marketing OfficerSell$254.59K
Mar 02, 2026Polymeropoulos Mihael Hristos President and CEOSell$1.28M
Mar 02, 2026Birznieks Gunther SVP, Business DevelopmentSell$350.73K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q1-6
2025 Q31-
2025 Q231
2025 Q111-

VNDA Ownership FAQ

Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 76.30%, followed by 6.16% insiders and 17.54% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Vanda Pharmaceuticals exceeds.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock (8.14M shares, 14.09%), Blackrock funding, inc. /de (7.28M shares, 12.31%), and Renaissance (3.76M shares, 6.36%). Together, they hold 32.76% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.19% of its assets in 1.18M Vanda Pharmaceuticals shares, valued at 8.16M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Vanda Pharmaceuticals shares, with 3.22% of its total shares outstanding invested in 1.94M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools